About Dosist
Dosist is a company based in Los Angeles (United States) founded in 2016 by Matt Seashols was acquired by Final Bell in November 2023. Dosist has raised $15 million across 1 funding round from investors including Turning Point Brands and Final Bell. The company has 2 employees as of December 31, 2022. Dosist offers products and services including Vaporization, Gummies, and Dose Pens. Dosist operates in a competitive market with competitors including Syqe, Kanabo, Fernway, Philter and Resolve Digital Health, among others.
- Headquarter Los Angeles, United States
- Employees 2 as on 31 Dec, 2022
- Founders Matt Seashols
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gsw Creative Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series B
Oct 27, 2020
-
Investors
Turning Point Brands
& 1 more
-
Employee Count
2
as on Dec 31, 2022
-
Acquired by
Final Bell
(Nov 16, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dosist
Dosist offers a comprehensive portfolio of products and services, including Vaporization, Gummies, and Dose Pens.
Devices for cannabis vaporization and wellness use.
Cannabis-infused gummies for health applications.
Pens for precise cannabis dosing and consumption.
Funding Insights of Dosist
Dosist has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Dosist
Dosist has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Turning Point Brands and Final Bell.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tobacco products are manufactured across multiple categories.
|
Locked | Locked | Locked | |
|
Child-resistant packaging and compliance services for cannabis products are provided.
|
Locked | Locked | Locked |
Investor details for Dosist
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dosist
Investment portfolio details for Dosist
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dosist
Detailed financials for Dosist
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dosist Comparisons
Peer comparison for Dosist
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dosist
Dosist operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syqe, Kanabo, Fernway, Philter and Resolve Digital Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precise dosing inhaler for medical cannabis is developed.
|
|
| Locked | Locked | Locked |
Cannabis-based medical and consumer products are developed by Kanabo.
|
|
| Locked | Locked | Locked |
Cannabis-based vaporizer cartridges with natural terpenes are provided.
|
|
| Locked | Locked | Locked |
Vapour cigarettes are branded and offered by Philter.
|
|
| Locked | Locked | Locked |
Smart inhalers and health monitoring devices are developed for wellness.
|
Detailed competitors of Dosist
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dosist
Complete news archive for Dosist
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dosist
Dosist was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Dosist is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Gunner Winston is the current CEO of Dosist.
Dosist is a funded company, having raised a total of $15M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Dosist is 2.
Dosist was founded in 2016 in Los Angeles, United States, as an integrated operation in the cannabis sector. Strains are sourced and processed to derive cannabinoids and terpenes, enabling the development of proprietary therapeutic products for medical use. Delivery devices, including dose-pens and dose-sprays, are supplied alongside formulations such as sleep, relaxation, pain relief, and euphoria recipes. Products undergo three levels of trials prior to release.
Dosist offers Vaporization, Gummies, and Dose Pens.
Dosist has 2 investors. Key investors include Turning Point Brands, and Final Bell.